• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Will They or Won't They?

    Morningstar markets editor Jeremy Glaser on how inflation may or may not affect policy, whether FedEx results mean a slowing economy, and if consumers will still stay loyal to Best Buy.

  2. Behind the Bullish Take on Our Top Pharma Pick

    A large generics business and niche pipeline keep Novartis ahead of the curve.

  3. An Opportunistic Pharma Pick

    Premature disappointment over the prospect of Vanda's sole drug has left investors with a compelling opportunity says Morningstar Opportunistic Investor's Stephen Ellis.

  4. Healthy Growth Prospects for This Pharma Pick

    Day 7: Growth from emerging markets as well as launched and pipeline products bode well for this pick.

  1. Novartis NVS Q4 2012 Earnings Call Transcript

    Good morning and good afternoon and welcome to the Novartis Q4 Full Year 2012 Results Conference Call and Live Video Webcast. Please note that during the presentation all participants will be in listen-only mode and the conference is being recorded. A recording of the conference call, including the ...

  2. Novartis AG NVS Q1 2012 Earnings Call Transcript

    Good day and welcome to the Novartis Conference Call. At this time, I would like to turn the conference over to Mr. Joe Jimenez, CEO of Novartis. Please go ahead, sir.

  3. Novartis AG NVS Q2 2012 Earnings Call Transcript

    Good morning and good afternoon and welcome to the Novartis Q2 Half Year 2012 Results Conference Call and Live Webcast. Please note that during the presentation all participants will be in a listen-only mode and the conference is being recorded.

  4. Breaking Bad Behaviors

     

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.